Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Problems with generic lunesta?Varenicline tartrate 0 5 mg tablet?Are there any unique features in apotex's ruxolitinib formulation?Paltusotine peak sales estimate?Indomethacin price increase 2023?
See the DrugPatentWatch profile for caplyta
Caplyta is the brand name for lumateperone, an oral prescription medicine used to treat certain mood disorders.1
Lumateperone (Caplyta) is prescribed for schizophrenia and depressive episodes associated with bipolar I or bipolar II disorder.1
Caplyta is a brand-name drug. Generic versions depend on patent and market exclusivity status, which can change over time.1
Caplyta is marketed by Intra-Cellular Therapies, Inc. (the company associated with the lumateperone brand).1
Caplyta (lumateperone) is an antipsychotic/psychotropic medication. Specific mechanisms are not detailed in the provided source.1 Sources:
Other Questions About Caplyta :